Effect of ionic strength on porphyrin drugs interaction with quadruplex DNA formed by the promoter region of C-myc and Bcl2 oncogenes

Journal of Nucleic Acids

Volumn 2010, Issue , 2010, Pages

  Nagesh, Narayana ^a   Sharma, Varun K ^a   Ganesh Kumar, A ^b   Lewis, Edwin A ^c  

^a CENTRE FOR CELLULAR AND MOLECULAR BIOLOGY   (India)

^b SATHYABAMA UNIVERSITY   (India)

^c MISSISSIPPI STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GUANINE QUADRUPLEX; MYC PROTEIN; OLIGONUCLEOTIDE; PORPHYRIN DERIVATIVE; POTASSIUM ION; PROTEIN BCL 2;

ARTICLE; BCL2 GENE; CIRCULAR DICHROISM; CONTROLLED STUDY; DNA STRUCTURE; DRUG DNA INTERACTION; DRUG STRUCTURE; FLUORESCENCE SPECTROSCOPY; IONIC STRENGTH; ONCOGENE; ONCOGENE C MYC; PRIORITY JOURNAL; PROMOTER REGION; STOICHIOMETRY; ULTRAVIOLET SPECTROSCOPY;

EID: 84860435791     PISSN: 20900201     EISSN: 2090021X     Source Type: Journal    
DOI: 10.4061/2010/146418     Document Type: Article

References (37)

1. Cohen J. J., Duke R. C., Glucocorticoid activation of a calcium-dependent endonuclease in thymocyte nuclei leads to cell death. Journal of Immunology 1984 132 1 38 42 EID2-s2.0-0021367846 (Pubitemid 14213827)
2. McDonnell T. J., Troncoso P., Brisbay S. M., Expression of the protooncogene bcl-2 in the prostate and its association with emergence of androgen-independent prostate cancer. Cancer Research 1992 52 24 6940 6944 EID2-s2.0-0027093255 (Pubitemid 23006303)
3. Baretton G. B., Diebold J., Christoforis G., Apoptosis and immunohistochemical bcl-2 expression in colorectal adenomas and carcinomas: aspects of carcinogenesis and prognostic significance. Cancer 1996 77 2 255 264 10.1002/(SICI)1097-0142(19960115)77:2255::AID-CNCR63.0.CO;2-L EID2-s2.0-0030024253 (Pubitemid 26023343)
4. Dang C. V., cvdang@welchlink.welch.jhu.edu c-Myc target genes involved in cell growth, apoptosis, and metabolism. Molecular and Cellular Biology 1999 19 1 1 11 (Pubitemid 29018404)
5. Dang C. V., cvdang@welch.jhu.edu Resar L. M. S., Emison E., Function of the c-Myc oncogenic transcription factor. Experimental Cell Research 1999 253 1 63 77 10.1006/excr.1999.4686
6. Cole M. D., The Myc oncogene: its role in transformation and differentiation. Annual Review of Genetics 1986 20 361 384
7. Henriksson M., Selivanova G., Lindstrm M., Wiman K. G., Inactivation of Myc-induced p53-dependent apoptosis in human tumors. Apoptosis 2001 6 1-2 133 137 10.1023/A:1009644716727 (Pubitemid 32233960)
8. Boxer L. M., Dang C. V., cvdang@jhmi.edu Translocations involving c-Myc and c-Myc function. Oncogene 2001 20 5595 5610 10.1038/sj.onc.1204595 (Pubitemid 32928100)
9. Bejugam M., Sewitz S., Shirude P. S., Rodriguez R., Shahid R., Balasubramanian S., sb10031@cam.ac.uk Trisubstituted isoalloxazines as a new class of G-quadruplex binding ligands: small molecule regulation of c-kit oncogene expression. Journal of the American Chemical Society 2007 129 43 12926 12927 10.1021/ja075881p (Pubitemid 350058320)
10. Sun D., Thompson B., Cathers B. E., Inhibition of human telomerase by a G-quadruplex-interactive compound. Journal of Medicinal Chemistry 1997 40 14 2113 2116 10.1021/jm970199z (Pubitemid 27284346)
11. Burger A. M., Dai F., Schultes C. M., The G-quadruplex-interactive molecule BRACO-19 inhibits tumor growth, consistent with telomere targeting and interference with telomerase function. Cancer Research 2005 65 4 1489 1496 10.1158/0008-5472.CAN-04-2910 (Pubitemid 40270178)
12. Fedoroff O. Y., Salazar M., Han H., Chemeris V. V., Kerwin S. M., Hurley L. H., NMR-based model of a telomerase-inhibiting compound bound to G-quadruplex DNA. Biochemistry 1998 37 36 12367 12374 10.1021/bi981330n (Pubitemid 28427520)
13. Riou J. F., Guittat L., Mailliet P., patrick.mailliet@aventis.com Cell senescence and telomere shortening induced by a new series of specific G-quadruplex DNA ligands. Proceedings of the National Academy of Sciences of the United States of America 2002 99 5 2672 2677 10.1073/pnas.052698099 (Pubitemid 34240519)
14. Fletcher T. M., tfletcher@med.miami.edu Telomerase: a potential therapeutic target for cancer. Expert Opinion on Therapeutic Targets 2005 9 3 457 469 10.1517/14728222.9.3.457 (Pubitemid 40883147)
15. Seenisamy J., Bashyam S., Gokhale V., Design and synthesis of an expanded porphyrin that has selectivity for the c-Myc G-quadruplex structure. Journal of the American Chemical Society 2005 127 9 2944 2959 10.1021/ja0444482 (Pubitemid 40349873)
16. Han F. X., Wheelhouse R. T., Hurley L. H., Interactions of TMPyP4 and TMPyP2 with quadruplex DNA. Structural basis for the differential effects on telomerase inhibition. Journal of the American Chemical Society 1999 121 15 3561 3570 10.1021/ja984153m EID2-s2.0-0033594341 (Pubitemid 29200264)
17. Kimura T., Kawai K., Fujitsuka M., Majima T., majima@sanken.osaka-u.ac.jp Detection of the G-quadruplex-TMPyP4 complex by 2-aminopurine modified human telomeric DNA. Chemical Communications 2006 4 401 402 10.1039/b514526k
18. Han H., Langley D. R., Rangan A., Hurley L. H., Selective interactions of cationic porphyrins with G-quadruplex structures. Journal of the American Chemical Society 2001 123 37 8902 8913 10.1021/ja002179j EID2-s2.0-0035913742 (Pubitemid 32884711)
19. Guliaev A. B., Leontis N. B., Cationic 5,10,15,20-tetrakis (N-methylpyridinium-4-yl) porphyrin fully intercalates at 5′ -CG- 3′ steps of duplex DNA in solution. Biochemistry 1999 38 47 15425 15437 10.1021/bi9913808 EID2-s2.0-0033598685 (Pubitemid 129503583)
20. Marzilli L. G., Banville D. L., Zon G., Wilson W. D., Pronounced 1H and 31P NMR spectral changes on meso-tetrakis(N-methylpyridinium-4-yl)porphyrin binding to tetradecaoligo-deoxyribonucleotides: evidence for symmetric, selective binding to 5′ CG 3′ sequences. Journal of the American Chemical Society 1986 108 14 4188 4192 EID2-s2.0-0000171197
21. Ohyama T., Mita H., Yamamoto Y., Binding of 5,10,15,20-tetrakis(N- methylpyridinium-4-yl)-21H,23H-porphyrin to an at-rich region of a duplex DNA. Biophysical Chemistry 2005 113 1 53 59 10.1016/j.bpc.2004.07.039 EID2-s2.0-11144282683 (Pubitemid 40029719)
22. Kim J. O., Lee Y. A., Yun B. H., Han S. W., Kwag S. T., Kim S. K., Binding of meso-tetrakis(N-methylpyridinium-4-yl)porphyrin to AT oligomers: effect of chain length and the location of the porphyrin stacking. Biophysical Journal 2004 86 2 1012 1017 EID2-s2.0-1142310679 (Pubitemid 38209545)
23. Ford K. G., Neidle S., Perturbations in DNA structure upon interaction with porphyrins revealed by chemical probes, DNA footprinting and molecular modelling. Bioorganic and Medicinal Chemistry 1995 3 6 671 677 10.1016/0968-0896(95)00052-I EID2-s2.0-0028997697
24. Lee S., Jeon S. H., Kim B. J., Han S. W., Jang H. G., Kim S. K., Classification of CD and absorption spectra in the Soret band of H2 TMPyP bound to various synthetic polynucleotides. Biophysical Chemistry 2001 92 1-2 35 45 10.1016/S0301-4622(01)00181-8 EID2-s2.0-0035975684 (Pubitemid 32799124)
25. Haq I., Trent J. O., Chowdhry B. Z., Jenkins T. C., Intercalative G-tetraplex stabilization of telomeric DNA by a cationic porphyrin. Journal of the American Chemical Society 1999 121 9 1768 1779 10.1021/ja981554t EID2-s2.0-0033541133 (Pubitemid 29132031)
26. Freyer M. W., Buscaglia R., Kaplan K., Cashman D., Hurley L. H., Lewis E. A., Biophysical studies of the c-Myc NHE III1 promoter: model quadruplex interactions with a cationic porphyrin. Biophysical Journal 2007 92 6 2007 2015 10.1529/biophysj.106.097246 EID2-s2.0-33947647457 (Pubitemid 46495264)
27. Fassman G. D., Nucleic acids. Handbook of Biochemistry and Molecular Biology 1975 Cleveland, Ohio, USA CRC
28. Plum G. E., Determination of oligonucleotide molar extinction coefficients. Current Protocols in Nucleic Acid Chemistry 2000 7.3 New York, NY, USA John Wiley & Sons 1 17
29. Pasternack R. F., Huber P. R., Boyd P., Aggregation of meso-substituted water-soluble porphyrins. Journal of the American Chemical Society 1972 94 13 4511 4517
30. Kalyanasundaram K., Photochemistry of water-soluble porphyrins: comparative study of isomeric tetrapyridyl- and tetrakis(N-methylpyridiniumyl) porphyrins. Inorganic Chemistry 1984 23 16 2453 2459 EID2-s2.0-33845470218
31. Hambright P., Gore T., Burton M., Synthesis and characterization of new isomeric water-soluble porphyrins. Tetra(2-N-methylpyridyl)porphine and tetra(3-N-methylpyridyl)porphine. Inorganic Chemistry 1976 15 9 2314 2315 EID2-s2.0-0000117042
32. Keating L. R., Szalai V. A., vszalai@umbc.edu Parallel-stranded guanine quadruplex interactions with a copper cationic porphyrin. Biochemistry 2004 43 50 15891 15900 10.1021/bi0483209 (Pubitemid 39665088)
33. Likussar W., Boltz D. F., Theory of continuous variations plots and a new method for spectrophotometric determination of extraction and formation constants. Analytical Chemistry 1971 43 10 1265 1272 EID2-s2.0-33947291698
34. Ingham K. C., On the application of Jobs method of continuous variation to the stoichiometry of protein-ligand complexes. Analytical Biochemistry 1975 68 2 660 663 EID2-s2.0-0016563662
35. Anantha N. V., Azam M., Sheardy R. D., Porphyrin binding to quadruplexed T4G4. Biochemistry 1998 37 9 2709 2714 10.1021/bi973009v EID2-s2.0-0032477950 (Pubitemid 28145723)
36. Lubitz I., Borovok N., Kotlyar A., Interaction of monomolecular G4-DNA nanowires with TMPyP: evidence for intercalation. Biochemistry 2007 46 45 12925 12929 10.1021/bi701301u EID2-s2.0-36048974553 (Pubitemid 350086214)
37. Suh D., Chaires J. B., Criteria for the mode of binding of DNA binding agents. Bioorganic and Medicinal Chemistry 1995 3 6 723 728 10.1016/0968- 0896(95)00053-J